Randomized phase II study of daily and alternate-day administration of S-1 for adjuvant chemotherapy in completely-resected stage I non-small cell lung cancer: results of the Setouchi Lung Cancer Group Study 1301

Peer Review reports

Original Submission
19 Jan 2021	Submitted	Original manuscript
9 Feb 2021	Author responded	Author comments - Norihito Okumura
Resubmission - Version 2
9 Feb 2021	Submitted	Manuscript version 2
18 Feb 2021	Reviewed	Reviewer Report
23 Feb 2021	Reviewed	Reviewer Report
10 Mar 2021	Reviewed	Reviewer Report
26 Mar 2021	Author responded	Author comments - Norihito Okumura
Resubmission - Version 3
26 Mar 2021	Submitted	Manuscript version 3
9 Apr 2021	Reviewed	Reviewer Report
15 Apr 2021	Reviewed	Reviewer Report
20 Apr 2021	Author responded	Author comments - Norihito Okumura
Resubmission - Version 4
20 Apr 2021	Submitted	Manuscript version 4
Publishing
21 Apr 2021	Editorially accepted
6 May 2021	Article published	10.1186/s12885-021-08232-6

Back to article page